Evotec Buys Bionamics For Shortcut To German Academic Gems
This article was originally published in The Pink Sheet Daily
Executive Summary
In a novel move to overcome the slowdown in outsourcing, small-molecule drug discovery company Evotec has bought asset manager Bionamics to more quickly progress assets originating in German academia.